Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

Q4 2024 Earnings Call Transcript March 27, 2025 Oxford Industries, Inc. beats earnings expectations. Reported EPS is $1.37, ...

Another wipeout is slamming Wall Street as worries build about a potentially toxic mix of worsening inflation and a U.S.

Key regulators are not recommending Lilly’s Kisunla be cleared for the European market. The company says it plans to appeal ...

U.S. stocks are tumbling following discouraging updates on inflation and how much U.S. households may be willing to spend ...

Megan Boswell, the Blountville, Tennessee, woman convicted of killing her 13-month-old child, has been transferred to a ...

After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...

NEW YORK (AP) — Another wipeout walloped Wall Street Friday, as the S&P 500 dropped 2% for one of its worst days in the last ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has entered into an exclusive license agreement with Novo Nordisk A/S for ...

Spring is the season of new beginnings and Dancing with the Stars is not exempt from this rule. It seems like we just finished with one of the most exciting ...

The survey predicted the increase would happen within the next six months. Other industry news is on health care access in rural areas; Pfizer's alleged attempt to avoid taxes; and more.

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), on Friday declined to endorse Kisunla ...